Watchdog Transparency Blog

Watchdog Transparency Blog

In our Blog we take a critical look at public company disclosures and focus on issues surrounding transparency, reliability and accuracy. It you are looking for cheerleading, you have come to the wrong place. We rely on information from the best sources available to gain insight into companies and make predictions about what will happen in the future. Nothing in business is certain, so sometimes we will be wrong, but we will always be an independent voice telling you the truth as we see it. We offer Retail Investors our Research Reports for Free.

Sign up to get all of our blogs delivered directly to your inbox.

Articles

Articles

On Trial: Personal Experience versus Hard Data


Posted on

There is a big difference between knowing that similar circumstances have rarely occurred and believing similar circumstances have never occurred.

Posted in

Small Companies 5X More Likely Than Large Companies to Report a Control Deficiency


Posted on

After the Enron scandal, Congress passed Sarbanes-Oxley (SOX) to improve the quality of financial reporting and deter fraud. One core reform was to require every company’s management team to annually assess and report on the effectiveness of the company’s disclosure controls.

Posted in

Foreign Restatements and Securities Class Action Suits


Posted on

Foreign companies have played an increasingly relevant role on the NYSE and NASDAQ over the last decade and currently comprise over 20% of those exchanges. We recently completed a report on the particular risks by foreign listings entitled Foreign Restatements and Securities Class Actions.

Posted in

The Impact of Securities Lawsuits


Posted on

In our research on securities class action lawsuits, we measure the impact of lawsuits by looking at abnormal returns over the 30-day period following a securities lawsuit. We calculate the abnormal returns by comparing how the company performed to how the S&P 500 performed on average over the same 30-day period.

Posted in

Restatements More Disruptive to Foreign Companies than U.S. Companies


Posted on

Investor Confidence in Foreign Companies is More Easily Shaken

Posted in

2020: U.S. Restatements Fall to 10-Year Low


Posted on

U.S. companies filed 42 restatements in 2020, the fewest ever.

Posted in

Biotech and Pharmaceutical Litigation in 2020


Posted on

Companies sustained record-setting levels of securities class action suits in 2017, 2018, and 2019 after the Supreme Court’s decision in Cyan threw open the doors of the state courts to traditionally federal securities litigation. In 2020, the number of securities class action suits filed receded from these all-time highs, but it is unclear whether the reduction is a temporary departure from a new paradigm, or the beginning a of a return to the mean.

Posted in
Total articles: 91(page 1 of 13 with 7 articles)
Watchdog Transparency Blog

Watchdog Transparency Blog

In our Blog we take a critical look at public company disclosures and focus on issues surrounding transparency, reliability and accuracy. It you are looking for cheerleading, you have come to the wrong place. We rely on information from the best sources available to gain insight into companies and make predictions about what will happen in the future. Nothing in business is certain, so sometimes we will be wrong, but we will always be an independent voice telling you the truth as we see it. We offer Retail Investors our Research Reports for Free.

Sign up to get all of our blogs delivered directly to your inbox.

Articles

Articles

On Trial: Personal Experience versus Hard Data


Posted on

There is a big difference between knowing that similar circumstances have rarely occurred and believing similar circumstances have never occurred.

Posted in

Small Companies 5X More Likely Than Large Companies to Report a Control Deficiency


Posted on

After the Enron scandal, Congress passed Sarbanes-Oxley (SOX) to improve the quality of financial reporting and deter fraud. One core reform was to require every company’s management team to annually assess and report on the effectiveness of the company’s disclosure controls.

Posted in

Foreign Restatements and Securities Class Action Suits


Posted on

Foreign companies have played an increasingly relevant role on the NYSE and NASDAQ over the last decade and currently comprise over 20% of those exchanges. We recently completed a report on the particular risks by foreign listings entitled Foreign Restatements and Securities Class Actions.

Posted in

The Impact of Securities Lawsuits


Posted on

In our research on securities class action lawsuits, we measure the impact of lawsuits by looking at abnormal returns over the 30-day period following a securities lawsuit. We calculate the abnormal returns by comparing how the company performed to how the S&P 500 performed on average over the same 30-day period.

Posted in

Restatements More Disruptive to Foreign Companies than U.S. Companies


Posted on

Investor Confidence in Foreign Companies is More Easily Shaken

Posted in

2020: U.S. Restatements Fall to 10-Year Low


Posted on

U.S. companies filed 42 restatements in 2020, the fewest ever.

Posted in

Biotech and Pharmaceutical Litigation in 2020


Posted on

Companies sustained record-setting levels of securities class action suits in 2017, 2018, and 2019 after the Supreme Court’s decision in Cyan threw open the doors of the state courts to traditionally federal securities litigation. In 2020, the number of securities class action suits filed receded from these all-time highs, but it is unclear whether the reduction is a temporary departure from a new paradigm, or the beginning a of a return to the mean.

Posted in
Total articles: 91(page 1 of 13 with 7 articles)
Watchdog Transparency Blog

Watchdog Transparency Blog

In our Blog we take a critical look at public company disclosures and focus on issues surrounding transparency, reliability and accuracy. It you are looking for cheerleading, you have come to the wrong place. We rely on information from the best sources available to gain insight into companies and make predictions about what will happen in the future. Nothing in business is certain, so sometimes we will be wrong, but we will always be an independent voice telling you the truth as we see it. We offer Retail Investors our Research Reports for Free.

Sign up to get all of our blogs delivered directly to your inbox.

Articles

Articles

On Trial: Personal Experience versus Hard Data


Posted on

There is a big difference between knowing that similar circumstances have rarely occurred and believing similar circumstances have never occurred.

Posted in

Small Companies 5X More Likely Than Large Companies to Report a Control Deficiency


Posted on

After the Enron scandal, Congress passed Sarbanes-Oxley (SOX) to improve the quality of financial reporting and deter fraud. One core reform was to require every company’s management team to annually assess and report on the effectiveness of the company’s disclosure controls.

Posted in

Foreign Restatements and Securities Class Action Suits


Posted on

Foreign companies have played an increasingly relevant role on the NYSE and NASDAQ over the last decade and currently comprise over 20% of those exchanges. We recently completed a report on the particular risks by foreign listings entitled Foreign Restatements and Securities Class Actions.

Posted in

The Impact of Securities Lawsuits


Posted on

In our research on securities class action lawsuits, we measure the impact of lawsuits by looking at abnormal returns over the 30-day period following a securities lawsuit. We calculate the abnormal returns by comparing how the company performed to how the S&P 500 performed on average over the same 30-day period.

Posted in

Restatements More Disruptive to Foreign Companies than U.S. Companies


Posted on

Investor Confidence in Foreign Companies is More Easily Shaken

Posted in

2020: U.S. Restatements Fall to 10-Year Low


Posted on

U.S. companies filed 42 restatements in 2020, the fewest ever.

Posted in

Biotech and Pharmaceutical Litigation in 2020


Posted on

Companies sustained record-setting levels of securities class action suits in 2017, 2018, and 2019 after the Supreme Court’s decision in Cyan threw open the doors of the state courts to traditionally federal securities litigation. In 2020, the number of securities class action suits filed receded from these all-time highs, but it is unclear whether the reduction is a temporary departure from a new paradigm, or the beginning a of a return to the mean.

Posted in
Total articles: 91(page 1 of 13 with 7 articles)
Watchdog Transparency Blog

Watchdog Transparency Blog

In our Blog we take a critical look at public company disclosures and focus on issues surrounding transparency, reliability and accuracy. It you are looking for cheerleading, you have come to the wrong place. We rely on information from the best sources available to gain insight into companies and make predictions about what will happen in the future. Nothing in business is certain, so sometimes we will be wrong, but we will always be an independent voice telling you the truth as we see it. We offer Retail Investors our Research Reports for Free.

Sign up to get all of our blogs delivered directly to your inbox.

Articles

Articles

On Trial: Personal Experience versus Hard Data


Posted on

There is a big difference between knowing that similar circumstances have rarely occurred and believing similar circumstances have never occurred.

Posted in

Small Companies 5X More Likely Than Large Companies to Report a Control Deficiency


Posted on

After the Enron scandal, Congress passed Sarbanes-Oxley (SOX) to improve the quality of financial reporting and deter fraud. One core reform was to require every company’s management team to annually assess and report on the effectiveness of the company’s disclosure controls.

Posted in

Foreign Restatements and Securities Class Action Suits


Posted on

Foreign companies have played an increasingly relevant role on the NYSE and NASDAQ over the last decade and currently comprise over 20% of those exchanges. We recently completed a report on the particular risks by foreign listings entitled Foreign Restatements and Securities Class Actions.

Posted in

The Impact of Securities Lawsuits


Posted on

In our research on securities class action lawsuits, we measure the impact of lawsuits by looking at abnormal returns over the 30-day period following a securities lawsuit. We calculate the abnormal returns by comparing how the company performed to how the S&P 500 performed on average over the same 30-day period.

Posted in

Restatements More Disruptive to Foreign Companies than U.S. Companies


Posted on

Investor Confidence in Foreign Companies is More Easily Shaken

Posted in

2020: U.S. Restatements Fall to 10-Year Low


Posted on

U.S. companies filed 42 restatements in 2020, the fewest ever.

Posted in

Biotech and Pharmaceutical Litigation in 2020


Posted on

Companies sustained record-setting levels of securities class action suits in 2017, 2018, and 2019 after the Supreme Court’s decision in Cyan threw open the doors of the state courts to traditionally federal securities litigation. In 2020, the number of securities class action suits filed receded from these all-time highs, but it is unclear whether the reduction is a temporary departure from a new paradigm, or the beginning a of a return to the mean.

Posted in
Total articles: 91(page 1 of 13 with 7 articles)

© 2020 Watchdog Research, Inc. All rights reserved.
Watchdog Transparency is a publication based on reports created by Watchdog Research, Inc.
Watchdog Research, Inc. is a financial research company providing due diligence information on public companies.

@WatchdogRsrch    |     rss